Table of Contents

Volume 1, Issue 4

  July/August 2009

  Pages 307 - 390

View covers archive

Guest Editorial

• Letter from the editor
  

  Janice M. Reichert
  Page 307

Meeting Reports

• 5th Annual Monoclonal Antibodies Conference 2009: March 24–25, 2009 London, UK

  Mari Herigstad and Lisa Urquhart
  Pages 308 - 317

• Keystone Symposium on Antibodies as Drugs: March 27–April 1, 2009, Whistler, BC Canada
  

  Thierry Wurch, Christel Labouret and Bruno Robert
  Pages 318 - 325

Mini-Review

• Ofatumumab

  Bodi Zhang
  Pages 326 - 331

Review

• Human immunoglobulin allotypes: Possible implications for immunogenicity

  Roy Jefferis and Marie-Paule Lefranc
  Pages 332 - 338

Reports

• Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-Ig^TM) molecules

  Chengbin Wu, Hua Ying, Sahana Bose, Renee Miller, Limary Medina, Ling Santora and Tariq Ghayur
  Pages 339 - 347

• Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics

  Stephen Thompson, John Dessi and Colin H. Self
  Pages 348 - 356

• Generation and characterization of chicken monoclonal antibodies against human LOX-1

  Open Access Article

  Shin Iwamoto, Norihisa Nishimichi, Yoshiko Tateishi, Yuko Sato, Hiroyuki Horiuchi, Shuichi Furusawa, Tatsuya Sawamura and Haruo Matsuda
  Pages 357 - 363

• Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration

  Yanmei Lu, Hong Xiang, Peter Liu, Raymond R. Tong, Ryan J. Watts, Alexander W. Koch, Wendy N. Sandoval, Lisa A. Damico, Wai Lee Wong and Y. Gloria Meng
  Pages 364 - 369

• Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro: Simple removal of non-viable cells improves antibody productivity by hybridoma cells in culture

  Christopher D. Gregory, John D. Pound, Andrew Devitt, Megan Wilson-Jones, Parthasarathi Ray and Ruth J. Murray
  Pages 370 - 376

Point of View

• Non-human primate immune libraries combined with germline humanization : An (almost) new and powerful approach for the isolation of therapeutic antibodies

  Thibaut Pelat and Philippe Thullier
  Pages 377 - 381

Special Focus: Patenting Antibodies

• Guardians at the gate: Patent protection for therapeutic monoclonal antibodies (Part 1)

  Kevin W. McCabe
  Pages 382 - 384

• Patenting antibodies in Europe

  Louise Holliday
  Pages 385 - 386

Editor's Corner

• Probabilities of success for antibody therapeutics

  Janice M. Reichert
  Pages 387 - 389

• Upcoming meetings

  Janice M. Reichert
  Page 390